TICKERNERD
Menu
CHECHEHealthcare · Medical Care Facilities

CHE Stock Forecast: Chemed Corp. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$513
+2.48% on the day

The 5 Wall Street analysts covering Chemed Corp. hold a median 12-month price target of $550 — +7.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 82 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$6.5B
Ticker Nerd rank
82 / 100
Median analyst target
$550
Analysts covering
5
Revenue$657.5M+1.6% y/y
Operating income$84.6M
Net income$66.3M
Free cash flow$71.1M
Quarterly, 7 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+2.3%
1M
−0.2%
YTD
+20.4%
1Y
+18.0%
From 52W high
−7.0%
From 52W low
+39.6%
$368
$552
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CHE stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Chemed Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
82 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
89
Quality
85
Revisions
78
Accruals
73
Value
67
Momentum
66
Issuance
56
Growth
51
Size
19

Volatility (89): The share price has been relatively steady.

Growth (51): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (19): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CHE stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CHE, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$300$400$500$600$700Jan 26Apr 26Jul 26Oct 26CHEHigh $650Median $550Low $520

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
2 Buy3 Hold0 Sell
Low $520Median $550High $650

The green dot is the last close — the median target sits +7.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
25 Sept 2026UBSInitiatesBuy$650
31 July 2026OppenheimerMaintainsOutperform$500 → $590
31 July 2026OppenheimerMaintainsOutperform—
30 July 2026RBC CapitalMaintainsSector Perform$436 → $548
30 July 2026RBC CapitalMaintainsSector Perform—
9 July 2026B of A SecuritiesMaintainsNeutral$450 → $510
9 July 2026B of A SecuritiesMaintainsNeutral—
27 Apr 2026RBC CapitalMaintainsSector Perform—
27 Feb 2026OppenheimerMaintainsOutperform—
27 Feb 2026RBC CapitalDowngradeSector Perform—
22 Jan 2026JefferiesDowngradeHold—
10 Nov 2025RBC CapitalMaintainsOutperform—
10 Sept 2025B of A SecuritiesMaintainsBuy—
2 Sept 2025JefferiesUpgradeBuy—
31 July 2025OppenheimerMaintainsOutperform—
31 July 2025RBC CapitalMaintainsOutperform—
25 July 2025JefferiesInitiatesHold—
30 June 2025B of A SecuritiesMaintainsBuy—
30 June 2025RBC CapitalMaintainsOutperform—
28 Apr 2025RBC CapitalMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CHE appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CHE vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Chemed Corp. returned +18.0% against +17.5% for the S&P 500, dividends included.

CHE vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130Jan 26Apr 26Jul 26Oct 26CHES&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CHE analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+4.7%
Analysts raising
0
Analysts cutting
1
Fundamentals

Chemed Corp. (CHE) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.2×

Cheaper than 30% of US stocks

Price / sales
2.5×

Cheaper than 46% of US stocks

Price / book
7.8×

Cheaper than 12% of US stocks

EV / EBITDA
16.2×

Cheaper than 20% of US stocks

Growth & margins
Revenue growth (YoY)
8.8%

Higher than 49% of US stocks

Earnings growth (YoY)
29.0%

Higher than 65% of US stocks

Gross margin
32.8%

Higher than 38% of US stocks

Operating margin
13.3%

Higher than 70% of US stocks

Net margin
10.6%

Higher than 71% of US stocks

Returns & dividend
Return on equity
27.1%

Higher than 86% of US stocks

Return on assets
13.5%

Higher than 96% of US stocks

Dividend yield
0.6%

Higher than 66% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Chemed Corp. (CHE) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Chemed Corp. has a market value of $6.5B and an enterprise value of $6.8B.

  • Revenue in the twelve months to 31 Mar 2026: $2.5B. The latest quarter grew 8.8% year on year.

  • Net income over the same four quarters: $259.8M, a 10.2% net margin.

  • Diluted earnings per share, trailing twelve months: $18.35.

  • Free cash flow in the twelve months to 31 Mar 2026: $377.1M, after $50.5M of capital spending.

  • Chemed Corp. spent $588.3M on share buybacks and $32.5M on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 13.1M.

  • Trailing P/E: 25.2×; forward P/E: 18.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.56%, paying out 12% of earnings.

  • Chemed Corp. employs 15,811 people — $161K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 15 Oct 2026

Data provided by Twelve Data

Peers

CHE vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
CHEChemed Corp.$6.5B
82
PACSPACS Group, Inc.$7.1B
88
OPCHOption Care Health, Inc.$4.9B
85
LFSTLifestance Health Group, Inc.$4.9B
94
CONConcentra Group Holdings Parent, Inc.$4.8B
96
ENSGThe Ensign Group, Inc.$10.2B
61
UHSUniversal Health Services, Inc.$11.0B
69

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Chemed Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CHE news & analysis

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

GlobeNewsWire · 1 Oct 2026neutral

Chemed Corporation announced it will release its third quarter 2026 financial results on Tuesday, October 27, 2026, after market close. The company will host a conference call and webcast the following morning, October 28, at 10 a.m.

Why it matters — CHE watchers will be alerted to the scheduled dates for the upcoming quarterly earnings release and related conference call.

Roto-Rooter Buys Largest Franchisee Territory

GlobeNewsWire · 16 Sept 2026positive

Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation, announced it has acquired the largest independent Roto-Rooter franchise, which serves approximately 11 million people, for $60.6 million.

Why it matters — The acquisition expands Roto-Rooter's corporate-owned service territory and could strengthen Chemed's market presence in a major population area.

Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript

Seeking Alpha · 15 Sept 2026neutral

Chemed Corporation presented at the 2026 Jefferies Healthcare Services and Technology Conference, with the event covered in a Seeking Alpha transcript. The presentation transcript documents Chemed's remarks at the conference.

Why it matters — CHE watchers would care because conference presentations can offer insight into the company's current positioning and outlook within the healthcare services sector.

Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference

GlobeNewsWire · 8 Sept 2026neutral

Chemed Corporation announced it will present at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m. The presentation will take place in Cincinnati per the announcement.

Why it matters — The presentation offers CHE watchers an opportunity to hear management discuss the company's business at a major healthcare industry conference.

Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040

The Motley Fool · 6 Sept 2026neutral

Chemed executive Spencer Lee sold 1,000 shares on Aug. 21 in a transaction valued at approximately $541,040. The sale reduced his direct equity holdings by 7%.

Why it matters — A corporate insider's share sale is noteworthy to CHE watchers as it reflects a change in the executive's direct ownership stake in the company.

FAQ

Frequently asked questions about CHE stock

What is the CHE stock price forecast for 2026-2027?

The 5 Wall Street analysts covering Chemed Corp. have a median 12-month price target of $550, with estimates ranging from $520 to $650. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CHE stock a buy right now?

Of the 5 analysts covering Chemed Corp., 2 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Chemed Corp. 82 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CHE?

As at 14 Oct 2026, Chemed Corp. ranks 82 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (89 of 100).

Will CHE stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +7.2% from the last close, and Ticker Nerd's factor model ranks Chemed Corp. 82 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CHE stock forecast for 2030?

No analyst covering Chemed Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CHE are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $520 to $650 over the next 12 months.

How has CHE stock performed over the past year?

Chemed Corp. returned +18.0% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Chemed Corp. do?

Chemed Corp. is a diversified holding company focused on healthcare and essential home services.

What is the latest news on CHE?

The most recent item we track (GlobeNewsWire, 1 Oct 2026): "Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28". Chemed Corporation announced it will release its third quarter 2026 financial results on Tuesday, October 27, 2026, after market close. The company will host a conference call and webcast the following morning, October 28, at 10 a.m.

Company

About Chemed Corp.

Chemed Corp. is a diversified holding company focused on healthcare and essential home services. Its operations are organized around two core segments: VITAS, which provides hospice and palliative care through a multidisciplinary network of clinicians and caregivers, and Roto-Rooter, which delivers plumbing, drain cleaning, excavation, and water restoration services to residential and commercial customers. Chemed Corp. serves patients, families, homeowners, businesses, and property managers across the United States, combining end-of-life care services with maintenance and emergency repair solutions. The company’s business model centers on operating specialized service brands with distinct customer needs and market dynamics, giving it a unique position in both healthcare services and home repair markets.

CEO Mr. Kevin J. McNamara · 15,811 employees · United States · https://www.chemed.com